University Of Trieste
- Address
- Via Dell' Istria 65, 34137 Trieste, Italy
University Of Trieste - Pediatric Rare Disease Research Center
The University of Trieste is actively engaged in international collaborative research focusing on rare pediatric hematologic disorders. The center participates in multicenter trials aimed at advancing treatment protocols for complex pediatric conditions requiring specialized multidisciplinary approaches and long-term follow-up strategies.
- Langerhans Cell Histiocytosis treatment optimization and salvage therapy protocols
- Prevention of disease reactivation and long-term sequelae in pediatric patients
- Comparative therapeutic strategies for single-system and multi-system disease presentations
The center's research emphasizes reducing mortality in multi-system disease through early intervention strategies and investigating optimal continuation therapy duration to minimize reactivations. Special attention is given to patients with CNS-risk lesions and risk organ involvement, utilizing randomized study designs to determine the most effective therapeutic approaches for both initial treatment and long-term disease management in children and adolescents.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in University Of Trieste
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Cladribine-Based Regimen in Pediatric and Adolescent Langerhans Cell Histiocytosis: A Randomized, Multicenter Clinical Trial | St. Anna Childrens Cancer Research Institute GmbH | Phase IV | Not Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Alemtuzumab | 1 | Unknown | 2024-10-09 | 2024-10-09 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.